TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

Mrinal M Gounder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.